Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Janssen Pharmaceutical K.K.
Nagaizumicho, Shizuoka, Japanjanssen.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Janssen Pharmaceutical K.K. (Japan affiliate of Janssen/Johnson & Johnson) has a broad commercial portfolio and late-stage pipeline in oncology, immunology, neuroscience, pain, and infectious diseases, including multiple approved and globally commercialized therapies. Key highlights include significant marketed products, major clinical collaborations, and a robust development pipeline with several advanced stage and marketed candidates.[4][5]
- Therapeutic areas
- OncologyNeurologyInfectious DiseasesImmunology
- Modalities
- Small moleculeMonoclonal antibodyBiologicRecombinant proteinKinase inhibitor
- Industry
- Pharma
02
Partnerships
Nippon Shinyaku
Beyond the preview
Go deeper on Janssen Pharmaceutical K.K..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Janssen Pharmaceutical K.K..